Kumar Rajat, Rao R Ranga, Rajagopal G, Singh V P
Reader in Medicine, Armed Forces Medical College, Pune.
Medical Oncologist, Armed Forces Medical College, Pune.
Med J Armed Forces India. 1995 Oct;51(4):231-236. doi: 10.1016/S0377-1237(17)30980-2. Epub 2017 Jun 26.
Twenty Hickman catheters were passed in 19 patients undergoing chemotherapy for acute leukemia (15 patients) and high grade lymphoma (4 patients). The catheters were inserted into the superior vena cava through the cephalic or external jugular vein with subcutaneous tunneling and exit through the anterior chest wall, and were functionally effective in 19 cases. The catheters remained in situ for a mean period of 50.5 days (range 1-266 days). The catheters were well tolerated eliminating the need for repeated venepuncture. The complications encountered were: hemorrhage - 1 case, thrombosis - 1 case, catheter related bacteremia - 2 cases, tunnel infection - 1 case, and exit site infection - 5 cases. Most of the complications were managed conservatively. These catheters ensured safe and reliable venous access in these high risk patients during episodes of severe neutropenia, sepsis and thrombocytopenia.
在19例接受急性白血病(15例)和高级别淋巴瘤(4例)化疗的患者中插入了20根Hickman导管。导管经头静脉或颈外静脉插入上腔静脉,皮下隧道化并从前胸壁引出,19例功能良好。导管留置的平均时间为50.5天(范围1 - 266天)。导管耐受性良好,无需反复静脉穿刺。遇到的并发症有:出血1例、血栓形成1例、导管相关菌血症2例、隧道感染1例和出口部位感染5例。大多数并发症采用保守治疗。这些导管确保了这些高危患者在严重中性粒细胞减少、败血症和血小板减少期间安全可靠的静脉通路。